Trial intelligence / Profile preview

Thioctic Acid in Diabetic Polyneuropathy (NATHAN 1)

NCT00977483Phase 3Completed

Sponsor
Meda
Start
May 1998
Primary completion
Jan 2005
Modality
Small Molecules
Countries
9
01

Overview

A Phase 3 trial of alpha-lipoic acid in diabetic polyneuropathy (DPN), sponsored by Meda. Started May 1998; status: completed.

02

Drugs

alpha-lipoic acid
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on NCT00977483.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00977483.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call